PHARMAKNOWLEDGE ApS: Financial statements 2023
CVR: 30523202
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
PHARMAKNOWLEDGE ApS (CVR 30523202) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -4,716 and a net result of DKK 37,740 compared with DKK -61,489 the year before. Equity in the 2023 report amounted to DKK 478,426. The solvency ratio was 99.7%.
- Gross Profit
- DKK -4,716
- Profit/Loss
- DKK 37,740
- Equity
- DKK 478,426
- Total Assets
- DKK 479,626
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -5K | 38K | 478K | - |
| 2022 | - | -4K | -61K | 441K | - |
| 2021 | - | 23K | 56K | 502K | - |
| 2020 | - | -4K | 18K | 496K | - |
| 2019 | - | -4K | 43K | 478K | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
PHARMAKNOWLEDGE ApS has published its annual report for 2022. Gross profit came to DKK -3,618, and the net result was DKK -61,489.
About PHARMAKNOWLEDGE ApS
PHARMAKNOWLEDGE ApS is a Danish company of the type Anpartsselskab based in Værløse, founded in 2008. The company is registered under the industry Computerkonsulentbistand og forvaltning af computerfaciliteter. The management consists of Lene Worsaae Dalby. The company is owned by Lene Worsaae Dalby. The company has 1 employee (2011). In 2025, the company reported a gross profit of DKK -5,254 and a net result of DKK 20,016 compared with DKK 47,554 the year before. Equity in the 2025 report amounted to DKK 545,996.